Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Accounts Payables: 2016-2024

  • Zepp Health's Accounts Payables rose 36.99% to $51.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $51.1 million, marking a year-over-year increase of 36.99%. This contributed to the annual value of $51.1 million for FY2024, which is 36.99% up from last year.
  • As of Q4 2024, Zepp Health's Accounts Payables stood at $51.1 million, which was up 36.99% from $37.3 million recorded in Q4 2023.
  • In the past 5 years, Zepp Health's Accounts Payables ranged from a high of $299.1 million in Q4 2020 and a low of $37.3 million during Q4 2023.
  • Its 3-year average for Accounts Payables is $51.5 million, with a median of $51.1 million in 2024.
  • In the last 5 years, Zepp Health's Accounts Payables crashed by 67.98% in 2022 and then spiked by 36.99% in 2024.
  • Quarterly analysis of 5 years shows Zepp Health's Accounts Payables stood at $299.1 million in 2020, then slumped by 30.88% to $206.7 million in 2021, then slumped by 67.98% to $66.2 million in 2022, then tumbled by 43.68% to $37.3 million in 2023, then soared by 36.99% to $51.1 million in 2024.
  • Its last three reported values are $51.1 million in Q4 2024, $37.3 million for Q4 2023, and $66.2 million during Q4 2022.